Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice
Interleukin-6 (IL-6) has emerged as an important mediator of fatty acid metabolism with paradoxical effects in the liver. Administration of IL-6 has been reported to confer protection against steatosis, but plasma and tissue IL-6 concentrations are elevated in chronic liver diseases, including fatty...
Main Authors: | Margarita Vida, Ana Luisa Gavito, Francisco Javier Pavón, Dolores Bautista, Antonia Serrano, Juan Suarez, Sergio Arrabal, Juan Decara, Miguel Romero-Cuevas, Fernando Rodríguez de Fonseca, Elena Baixeras |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2015-07-01
|
Series: | Disease Models & Mechanisms |
Subjects: | |
Online Access: | http://dmm.biologists.org/content/8/7/721 |
Similar Items
-
Chronic IL-6 Administration Desensitizes IL-6 Response in Liver, Causes Hyperleptinemia and Aggravates Steatosis in Diet-Induced-Obese Mice.
by: Ana Luisa Gavito, et al.
Published: (2016-01-01) -
Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1 s⃞
by: Gizem Rizki, et al.
Published: (2006-10-01) -
Liver-Specific Activation of AMPK Prevents Steatosis on a High-Fructose Diet
by: Angela Woods, et al.
Published: (2017-03-01) -
CD36-deficient mice are resistant to alcohol- and high-carbohydrate-induced hepatic steatosis[S]
by: Robin D. Clugston, et al.
Published: (2014-02-01) -
Alterations in the Transcriptional Profile of the Liver Tissue and the Therapeutic Effects of Propolis Extracts in Alcohol-induced Steatosis in Rats
by: MANHONG YE, et al.